APA (7th ed.) Citation

Arii, K., Suehiro, T., Kumon, Y., Sugiura, T., Hashimoto, K., Yamanaka, S., & Ikeda, Y. (2007). Clinical implication of plasma lysophosphatidylcholine in type 2 diabetics. Japanese Journal of Clinical Chemistry, 36(1), 49-60. https://doi.org/10.14921/jscc1971b.36.1_49

Chicago Style (17th ed.) Citation

Arii, Kaoru, Tadashi Suehiro, Yoshitaka Kumon, Tetsuro Sugiura, Kozo Hashimoto, Shigeo Yamanaka, and Yukio Ikeda. "Clinical Implication of Plasma Lysophosphatidylcholine in Type 2 Diabetics." Japanese Journal of Clinical Chemistry 36, no. 1 (2007): 49-60. https://doi.org/10.14921/jscc1971b.36.1_49.

MLA (9th ed.) Citation

Arii, Kaoru, et al. "Clinical Implication of Plasma Lysophosphatidylcholine in Type 2 Diabetics." Japanese Journal of Clinical Chemistry, vol. 36, no. 1, 2007, pp. 49-60, https://doi.org/10.14921/jscc1971b.36.1_49.